ISSN 1674-3865  CN 21-1569/R
主管:国家卫生健康委员会
主办:中国医师协会
   辽宁省基础医学研究所
   辽宁中医药大学附属医院

中国中西医结合儿科学 ›› 2023, Vol. 15 ›› Issue (4): 351-355.doi: 10.3969/j.issn.1674-3865.2023.04.017

• 小儿中药应用研究 • 上一篇    下一篇

小儿定喘颗粒治疗儿童病毒性肺炎(痰热闭肺证)的临床研究

高媛媛, 王雪峰, 张秀英, 孟斌, 鄂明欣, 王辉   

  1. 110000 沈阳,辽宁中医药大学2021级中西医结合临床专业研究生(高媛媛);辽宁中医药大学附属医院儿科(王雪峰,张秀英);117000 辽宁 本溪,本溪满洲自治县中医院儿科(孟斌);110000 沈阳,辽宁中医药大学(鄂明欣);110000 沈阳,辽宁中医药大学2022级中医儿科学专业研究生(王辉)

  • 收稿日期:2023-06-14 出版日期:2023-08-25 上线日期:2023-08-25
  • 通讯作者: 王雪峰,E-mail:lnzywxf@163.com

Clinical study on Xiaoer Dingchuan granules in treating viral pneumonia in children (Phlegm-heat blocking lung syndrome) 

GAO Yuanyuan, WANG Xuefeng, ZHANG Xiuying, MENG Bin, E Mingxin, WANG Hui   

  1. Liaoning University of Traditional Chinese Medicine, Shenyang 110000,China

  • Received:2023-06-14 Published:2023-08-25 Online:2023-08-25
  • Contact: WANG Xuefeng,E-mail:lnzywxf@163.com

摘要: 目的 评价小儿定喘颗粒治疗小儿病毒性肺炎(痰热闭肺证)的疗效和临床应用的安全性。方法 选取辽宁中医药大学附属医院和满洲自治县中医院在2023年1月至6月确诊为病毒性肺炎患儿60例,随机分为观察组和对照组各30例。基于对照组布地奈德雾化吸入基础治疗以及对症治疗,观察组分别按儿童年龄给予相应剂量的小儿定喘颗粒。疗程为7 d,疗程结束后观察(1)儿童病毒性肺炎症状积分改善的总有效率;(2)儿童病毒性肺炎中医证候改善的总有效率;(3)儿童病毒性肺炎单症治疗的有效率及消失率;(4)不良反应/事件发生率。结果 因患者失访或更换药物造成病例共脱落3例,3例中观察组因失访脱落1例,对照组因失访脱落1例,因更换药物脱落1例,最终共有57例纳入统计分析。治疗7 d后,观察组在改善儿童病毒性肺炎症状积分改善的总有效率,中医证候改善的总有效率,单症治疗消失率和咳嗽、喉间痰鸣或咳痰症状总有效率方面均明显优于对照组,两组组间差异有统计学意义(P<0.05),喘息、发热、肺部啰音症状总有效率组间比较,差异无统计学意义(P>0.05)。不良反应/事件方面,治疗期间观察组出现腹泻事件1例,不良反应发生率为3.45%(1/29),对照组在观察期间发生腹泻事件1例,恶心呕吐事件2例,对照组的不良反应/事件发生率为10.71%(3/28)。两组不良反应/事件发生率比较差异无统计学意义(P>0.05)。结论 小儿定喘颗粒能有效改善儿童病毒性肺炎症状以及中医证候,对儿童病毒性肺炎典型症状,喘息、咳嗽、喉间痰鸣或咳痰、发热、肺部听诊症状的疗效以及消失率有显著作用,且不良反应发生率低,临床应用安全性较高。

关键词: 病毒性肺炎, 痰热闭肺, 小儿定喘颗粒, 随机对照, 儿童

Abstract: Objective To evaluate the efficacy of Xiaoer Dingchuan granules on viral pneumonia in children (phlegm-heat blocking lung syndrome) and the safety of clinical application of Xiaoer Dingchuan granules.Methods Sixty children diagnosed with viral pneumonia in the Affiliated Hospital of Liaoning University of Traditional Chinese Medicine and the Hospital of Traditional Chinese Medicine of Manzhou Autonomous County from January 2023 to June 2023 were selected and divided into experimental group and control group by random number table method, with 30 children in each group. Based on the basic treatment and symptomatic treatment of budesonide aerosol inhalation in the control group, the experimental group was given corresponding doses of Xiaoer Dingchuan granules according to the age of children. The course of treatment was 7 days. At the end of treatment course, we observed (1) the total effective rate of the symptom improvement score of viral pneumonia in children; (2) total effective rate of improvement of TCM syndromes of viral pneumonia in children; (3) the efficacy and disappearance rate of single symptom treatment for viral pneumonia in children; (4) incidence of adverse reactions/events.Results A total of 3 cases were lost due to patient loss of follow-up or drug replacement. Among the 3 cases, 1 case was lost due to loss of follow-up in the observation group, 1 case was lost due to loss of follow-up in the control group, and 1 case was lost due to drug replacement in the control group. Finally, a total of 57 cases were included in the statistical analysis. After 7 days of treatment, the observation group was significantly better than the control group in the total effective rate of symptom improvement score in children's Viral pneumonia, the total effective rate of TCM syndrome improvement, the disappearance rate in single symptom treatment, and the total effective rate in cough, throat phlegm or sputum symptoms. The difference between the two groups was statistically significant (P<0.05);however, the difference between the two groups was not statistically significant(P>0.05) in the total effective rate in wheezing, fever or lung rales. In terms of adverse reactions/events, during the treatment period, there was 1 case of diarrhea event in the observation group, with an incidence rate of 3.45% (1/29). During the observation period, there was 1 case of diarrhea event and 2 cases of nausea and vomiting event in the control group, with an incidence rate of 10.71% (3/28) in the control group. There was no statistically significant difference in the incidence of adverse reactions/events between the two groups (P>0.05).Conclusion Xiaoer Dingchuan granules can effectively improve the symptoms and TCM syndromes of viral pneumonia in children, and have a significant effect on the typical symptoms of viral pneumonia in children, such as wheezing, cough, phlegm or sputum in the throat, fever, pulmonary auscultation symptoms and disappearance rate; the incidence of adverse reactions is low, and the clinical application is safe.

Key words:

Viral pneumonia, Phlegm-heat blocking lung, Xiaoer Dingchuan granules, Randomized control, Children